June 22, 2020 / 11:34 AM / 12 days ago

BRIEF-Altimmune Announces IND Clearance For Phase 2 Trial Of Heptcell

June 22 (Reuters) - Altimmune Inc:

* ALTIMMUNE ANNOUNCES IND CLEARANCE FOR A PHASE 2 TRIAL OF HEPTCELL™ IMMUNOTHERAPEUTIC FOR THE TREATMENT OF CHRONIC HEPATITIS B

* ALTIMMUNE - PLANS TO INITIATE MULTINATIONAL TRIAL IN Q4 THIS YEAR, SUBJECT TO AN ONGOING ASSESSMENT OF IMPACT OF COVID-19 ON STUDY CONDUCT Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below